This inventor holds 1 USPTO granted patent. Top assignees: Hikal Limited, Indian Institute of Science. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 7 
1 out of 145 
Years Active: 2009
Title: Suresh Babu Balakrishnan: Innovator in Pharmaceutical Chemistry
Introduction
Suresh Babu Balakrishnan is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on gabapentin analogues. His research has implications for the development of new therapeutic agents.
Latest Patents
One of his key patents is titled "Gabapentin analogues and process thereof." This invention relates to the compounds trans (E) and cis (Z) stereoisomers of 4-t-butyl gabapentin, represented by formulas (11) and (12). The patent outlines a process for the preparation of these stereoisomers, which can be crucial for enhancing the efficacy of gabapentin-related treatments.
Career Highlights
Suresh Babu Balakrishnan has worked with prominent organizations such as Hikal Limited and the Indian Institute of Science. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to various research initiatives.
Collaborations
Throughout his career, he has collaborated with notable colleagues, including Nagarajan Kuppuswamy and Sivaramakrishnan Hariharan. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Suresh Babu Balakrishnan's work exemplifies the importance of innovation in pharmaceutical chemistry. His contributions, particularly in the development of gabapentin analogues, highlight his role as a key inventor in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile